组蛋白乙酰转移酶
组蛋白乙酰转移酶
CREB结合蛋白
药理学
生物利用度
化学
乙酰转移酶
奶油
组蛋白
生物化学
乙酰化
生物
转录因子
基因
作者
Jonathan E. Wilson,Gaurav K. Patel,Chirag Patel,François Brucelle,Annissa J. Huhn,A.S. Gardberg,Florence Poy,Nico Cantone,Archana Bommi‐Reddy,Robert J. Sims,Richard Cummings,Julian Levell
标识
DOI:10.1021/acsmedchemlett.0c00155
摘要
The histone acetyltransferases, CREB binding protein (CBP) and EP300, are master transcriptional co-regulators that have been implicated in numerous diseases, such as cancer, inflammatory disorders, and neurodegeneration. A novel, highly potent, orally bioavailable EP300/CBP histone acetyltransferase (HAT) inhibitor, CPI-1612 or 17, was developed from the lead compound 3. Replacement of the indole scaffold of 3 with the aminopyridine scaffold of 17 led to improvements in potency, solubility, and bioavailability. These characteristics resulted in a 20-fold lower efficacious dose for 17 relative to lead 3 in a JEKO-1 tumor mouse xenograft study.
科研通智能强力驱动
Strongly Powered by AbleSci AI